Patents by Inventor Shaobin Shang

Shaobin Shang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T-CELL EPITOPE POLYPEPTIDE OF SENECAVIRUS A AND USES THEREOF
    Publication number: 20250084132
    Abstract: A T-cell epitope polypeptide of Senecavirus A (SVA) having an amino acid sequence represented by one of SEQ ID NOs: 1-7: SEQ ID NO: 1: DEALGRVLTPAAVDEALVDL; SEQ?ID?NO:?2: AILAKLGLALAAVTPGLIIL; SEQ?ID?NO:?3: KASPVLQYQL; SEQ?ID?NO:?4: EMKKLGPVAL; SEQ?ID?NO:?5: AHDAFMAGSG; SEQ?ID?NO:?6: PPLGDDQIEYLQVLKSLALT; and SEQ?ID?NO:?7: LASTLIAQAVSKRLYGSQSV.
    Type: Application
    Filed: September 12, 2024
    Publication date: March 13, 2025
    Inventors: Huichen GUO, Suyu MU, Shiqi SUN, Shaobin SHANG, Lingbo CHEN, Manyuan BAI, Yun ZHANG, Jinen WU, Shuanghui YIN, Zhidong TENG, Jingjing ZHOU, Hu DONG
  • T-CELL EPITOPE POLYPEPTIDE OF FOOT AND MOUTH DISEASE VIRUS AND USES THEREOF
    Publication number: 20250084131
    Abstract: A T-cell epitope polypeptide of foot and mouth disease virus (FMDV) having an amino acid sequence represented by one of SEQ ID Nos: 1-11: SEQ ID NO: 1: KGKPFNSKVIIATTNLYS; SEQ ID NO: 2: PLQNVYQLVQEVIDRVEL; SEQ ID NO: 3: VVMDDLGQNPDGKDFKYF; SEQ ID NO: 4: YNQQTVVVMDDLGQNPDG; SEQ ID NO: 5: GRTDSVWYCPPDPDHFDG; SEQ ID NO: 6: RGKSGQGKSFLANVLAQA; SEQ ID NO: 7: PDFNRLVSAFEELATGVK; SEQ ID NO: 8: AIRTGLDEAKPWYKLIKL; SEQ ID NO: 9: MSTKHGPDFNRLVSAFEE; SEQ ID NO: 10: MLDGRTMTDSDYRVF; and SEQ ID NO: 11: VLDEVIFSKHKGDTK.
    Type: Application
    Filed: September 4, 2024
    Publication date: March 13, 2025
    Inventors: Shiqi SUN, Huichen GUO, Suyu MU, Shaobin SHANG, Lingbo CHEN, Yun ZHANG, Manyuan BAI, Jinen WU, Shuanghui YIN, Zhidong TENG, Jingjing ZHOU, Hu DONG
  • Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses
    Patent number: 12194084
    Abstract: Provided herein are subunit vaccine compositions comprising a nanocarrier and a lipid antigen, a peptide antigen or combinations thereof that elicit bother a CD1-restricted and an MHC-restricted T cell response in a subject. Methods for making and using the subunit vaccine compositions are also provided.
    Type: Grant
    Filed: December 20, 2021
    Date of Patent: January 14, 2025
    Assignee: Northwestern University
    Inventors: Evan A. Scott, Chyung-Ru Wang, Shaobin Shang, Dina Kats
  • MULTI-SUBUNIT VACCINES TO ELICIT BOTH MHC- AND CD1-RESTRICTED T CELL RESPONSES
    Publication number: 20220184197
    Abstract: Provided herein are subunit vaccine compositions comprising a nanocarrier and a lipid antigen, a peptide antigen or combinations thereof that elicit bother a CD1-restricted and an MHC-restricted T cell response in a subject. Methods for making and using the subunit vaccine compositions are also provided.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 16, 2022
    Inventors: Evan A. Scott, Chyung-Ru Wang, Shaobin Shang, Dina Kats
  • Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses
    Patent number: 11202823
    Abstract: Provided herein are subunit vaccine compositions comprising a nanocarrier and a lipid antigen, a peptide antigen or combinations thereof that elicit bother a CD1-restricted and an MHC-restricted T cell response in a subject. Methods for making and using the subunit vaccine compositions are also provided.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: December 21, 2021
    Assignee: Northwestern University
    Inventors: Evan A. Scott, Chyung-Ru Wang, Shaobin Shang, Dina Kats
  • MULTI-SUBUNIT VACCINES TO ELICIT BOTH MHC- AND CD1-RESTRICTED T CELL RESPONSES
    Publication number: 20200316186
    Abstract: Provided herein are subunit vaccine compositions comprising a nanocarrier and a lipid antigen, a peptide antigen or combinations thereof that elicit bother a CD1-restricted and an MHC-restricted T cell response in a subject. Methods for making and using the subunit vaccine compositions are also provided.
    Type: Application
    Filed: April 3, 2020
    Publication date: October 8, 2020
    Applicant: Northwestern University
    Inventors: Evan A. Scott, Chyung-Ru Wang, Shaobin Shang, Dina Kats